US-listed Eyenovia acquires 1 million Hyperliquid tokens

Son Min

Summary

Eyenovia has announced the acquisition of approximately 1.04 million Hyperliquid (HYPE) tokens, becoming the first Nasdaq-listed company to do so.
This purchase was made as part of a $50 million fundraise via private placement, with the average token purchase price said to be about $34.
The company plans to start validator operations with its Hyperliquid tokens, and also intends to change its company and ticker name to Hyperion DeFi and 'HYPD', respectively.

Eyenovia, a pharmaceutical company listed on Nasdaq, announced that it has acquired 1 million Hyperliquid (HYPE) tokens. Previously, Eyenovia had promoted a plan to raise $50 million through a private placement investment.

On the 23rd (local time), Eyenovia stated in a press release, "With the successful completion of the fundraising, we have secured 1,040,584 HYPE tokens," adding, "We also plan to begin validator operations through these tokens." The average purchase price per token is around $34.

Michael Rowe, CEO of Eyenovia, said, "As crypto asset adoption grows, accumulating Hyperliquid will create long-term value for our shareholders."

Hyunsoo Jung, CIO of Eyenovia, noted, "Our early accumulation of Hyperliquid enables deeper connections with the ecosystem."

Meanwhile, Eyenovia is the first US-listed company to stockpile Hyperliquid. Additionally, it announced plans to change the company name and ticker to Hyperion DeFi and 'HYPD', respectively.

HYPE